Gyre Therapeutics (GYRE) Preferred Shares Issued (2015)
Gyre Therapeutics (GYRE) reported Preferred Shares Issued of $4.0 million for Q3 2015, up 36454.55% on a QoQ basis from -$11000.0 in Q2 2015.
Gyre Therapeutics (GYRE) has 1 years of Preferred Shares Issued data on file, last reported at $4.0 million in Q3 2015.
- Quarterly Preferred Shares Issued changed N/A year-over-year to $4.0 million in Q3 2015, while the trailing twelve-month figure through Dec 2015 was $7.3 million (changed N/A YoY) and the FY2015 annual result came in at $7.3 million, up 45.7% from the prior year.
- Preferred Shares Issued climbed to $4.0 million in Q3 2015 per GYRE's latest filing, from -$11000.0 in the prior quarter.
- Across five years, Preferred Shares Issued topped out at $4.0 million in Q3 2015 and bottomed at -$11000.0 in Q2 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 4.00 Mn |
| Sep 30, 2015 | 4.00 Mn |
| Jun 30, 2015 | -11,000.00 |
| Jun 30, 2015 | -11,000.00 |
| Mar 31, 2015 | 3.27 Mn |
| Mar 31, 2015 | 3.27 Mn |